In the established model of mammalian cell cycle control, the retinoblastoma protein (Rb) functions to restrict cells from entering S phase by binding and sequestering E2f activators (E2f1, E2f2 and E2f3), which are invariably portrayed as the ultimate effectors of a transcriptional program that commit cells to enter and progress through S phase 1, 2 . Using a panel of tissue-specific cre-transgenic mice and conditional E2f alleles we examined the effects of E2f1, E2f2 and E2f3 triple deficiency in murine embryonic stem cells, embryos and small intestines. We show that in normal dividing progenitor cells E2f1-3 function as transcriptional activators, but contrary to the current view, are dispensable for cell division and instead are necessary for cell survival. In differentiating cells E2f1-3 function in a complex with Rb as repressors to silence E2f targets and facilitate exit from the cell cycle. The inactivation of Rb in differentiating cells resulted in a switch of E2f1-3 from repressors to activators, leading to the superactivation of E2f responsive targets and ectopic cell divisions. Loss of E2f1-3 completely suppressed these phenotypes caused by Rb deficiency. This work contextualizes the activator versus repressor functions of E2f1-3 in vivo, revealing distinct roles in dividing versus differentiating cells and in normal versus cancer-like cell cycles.
E2fs function as transcription factors, with E2f1-3 as activators and E2f4-8 as repressors [3] [4] [5] [6] [7] [8] . Although it is a maxim of mammalian cell cycle regulation that the E2f1-3 activator subclass is required for cell proliferation, the evidence for this is based almost exclusively on in vitro studies using cells derived from murine and human tissues or on the in vivo analysis of Rb mutant mice 1, 2 . Other experiments, however, suggest that these E2fs can also function as repressors in complex with Rb 9-11 , yet the relative contribution of activation versus repression and the physiological contexts in which these contrary E2f functions are used remain unclear.
To explore the functions of the E2f activator subclass, we derived E2f1 2/2 E2f2 2/2 E2f3 loxP/2 embryonic stem (ES) cells ( Supplementary  Fig. 1a, b ) and compared the consequences of inactivating the conditional E2f3 loxP allele in ES cells and E2f1 2/2 E2f2 2/2 E2f3 loxP/loxP mouse embryonic fibroblasts (MEFs). The expression of E2f1, E2f2 and E2f3 in wild-type ES cells was generally higher than in MEFs and the loading of E2f3 protein on classic E2f target promoters was comparable between the two proliferating cell types ( Supplementary  Fig. 2a -c). Consistent with previous observations, the ablation of E2f1-3 in MEFs with standard cre-expressing vectors led to the induction of p53 activity, the loading of E2f4-p130 repressor complexes on E2f target promoters and a marked decrease in E2f target expression ( Fig. 1a and Supplementary Fig. 3a -c) [5] [6] [7] . Consequently, triply deficient MEFs underwent a complete cell cycle arrest ( Fig. 1b ) [5] [6] [7] . In contrast, E2f1 2/2 E2f2 2/2 E2f3 D/2 ES cells failed to activate p53 or form E2f4-p130 repressive complexes, and as a result, E2f target expression was unaffected and cells proliferated equally well as E2f1 2/2 E2f2 2/2 E2f3 loxP/2 double knockout control cells ( Fig. 1b and Supplementary Fig. 3a -c).
We then evaluated whether triply-deficient ES cells could proliferate in vivo. Subcutaneous injection of E2f1 2/2 E2f2 2/2 E2f3 D/2 ES cells into athymic nude mice yielded efficient teratoma formation, producing mesoderm, endoderm and ectoderm at a rate similar to E2f1 2/2 E2f2 2/2 E2f3 loxP/2 double knockout ES cell lines ( Fig. 1c and Supplementary Fig. 4a, b ). Moreover, from E2f1 1/2 E2f2 2/2 E2f3 1/2 intercrosses we recovered the expected number of live E2f1 2/2 E2f2 2/2 E2f3 D/2 triple knockout embryos as late as embryonic day (E)9.5, but none was recovered past E11.5 ( Fig. 1d and data not shown). The live E9.5 E2f1 2/2 E2f2 2/2 E2f3 D/2 embryos appeared morphologically normal by gross and histological examination ( Fig. 1e and data not shown). Although cell proliferation was normal in most tissues, there was evidence of decreased proliferation and increased apoptosis in the myocardium and the first branchial arch of E2f1 2/2 E2f2 2/2 E2f3 D/2 embryos ( Supplementary Fig. 5a-d ). These latter observations are consistent with heart defects found in E2f3 singly-deleted adult mice 12 .
To explore whether E2f1-3 might have cell-cycle-related functions in tissues that arise later in embryonic and postnatal development, we exploited the highly organized cellular architecture of the small intestine. Maintenance of structural and functional integrity of the small intestine requires continuous epithelial regeneration 13 . Intestinal stem cells are housed at the base of crypts of Lieberkühn and give rise to transit-amplifying cells. As these cells migrate up from the base and into the finger-like extensions called villi, they exit the cell cycle and differentiate 13 . Western blot assays showed that E2f1, E2f2 and both isoforms of E2f3 (E2f3a and E2f3b) are expressed in the crypt and villus ( Supplementary Fig. 6 ). We used Ah-cre mice 14 to ablate E2f1-3 in the small intestine in utero or in adult mice (Ah-creE2f1 2/2 E2f2 2/2 E2f3 loxP/loxP triple knockout). Induction of Ah-cre expression by intraperitoneal injection of b-napthoflavone (b-NF) led to the efficient deletion of E2f3 loxP in crypt stem cells and transit-amplifying cells by 1 day after injection, and in the entire intestinal epithelium within 3-4 days (crypt and villus; Supplementary Fig. 7a -c). Loss of E2f1-3 did not result in a compensatory increase of other E2f family members, except for a modest increase in E2f8 ( Supplementary Fig. 7d ). Whether E2f3 loxP was deleted in utero at E15.5 or in the adult at 2 months of age, the architecture of Ah-creE2f1 2/2 E2f2 2/2 E2f3 loxP/loxP small intestines remained relatively intact and animals were asymptomatic for 90 days after b-NF administration ( Fig. 2a and Supplementary Fig. 8a, b ). Cell-typespecific marker analysis demonstrated that all differentiated epithelial cell types were appropriately represented in b-NF treated Ah-creE2f1 2/2 E2f2 2/2 E2f3 loxP/loxP (E2f1-3-deficient) small intestines ( Fig. 2b and Supplementary Fig. 9 ). Remarkably, cell proliferation was identical in E2f1-3-deficient and control intestines ( Fig. 2c ); however, we noted a marked increase in the phosphorylation of H2AX (c-H2AX) and ataxia telangiectasia (P-ATM 1981 ) proteins in E2f1-3-deficient crypts and villi (Fig. 2d , e and Supplementary  Fig. 10a ). A parallel analysis of retinal 15 and lens (P.L.W., unpublished observations) progenitors also revealed increased c-H2AX staining in E2f1-3-deficient samples ( Supplementary Fig. 10b , c). Together, these observations suggest that counter to current dogma, E2f1-3 are dispensable for the proliferation of ES cells and their mesodermal, endodermal and ectodermal derivatives, and for the proliferation of cells in at least some adult tissues.
Close examination of haematoxylin-and-eosin-stained slides revealed increased numbers of pyknotic nuclei in E2f1-3-deficient crypts (data not shown). TdT-mediated dUTP nick end labelling (TUNEL) and cleaved caspase-3 assays confirmed the presence of apoptotic cells in crypts of E2f1-3-deficient intestines (Fig. 2f ). We also observed increased p53 immunoreactivity in E2f1-3-deficient crypts ( Supplementary Fig. 11a ), which was reminiscent of previous work showing exquisite sensitivity of this cellular compartment to oncogene-and radiation-induced p53 responses 16 DKO  TKO  DKO  TKO  DKO  TKO  DKO  TKO  DKO  TKO  DKO  TKO  DKO  TKO Supplementary Fig. 19 ). DKO, E2f1 2/2 E2f2 2/2 E2f3 loxP/2 (double knockout); TKO, E2f1 2/2 E2f2 2/2 E2f3 D/2 (triple knockout). Error bars represent standard deviation from samples analysed in triplicate. b, Growth curves of two sets of E2f1 2/2 E2f2 2/2 E2f3 loxP/2 (DKO) and E2f1 2/2 E2f2 2/2 E2f3 D/2 (TKO) ES cell clones (A and B; right two panels), and control-vector treated E2f1 2/2 E2f2 2/2 E2f3 loxP/loxP (DKO, left panel) and cre-vector treated E2f1 2/2 E2f2 2/2 E2f3 loxP/loxP MEFs (TKO, left panel). c, Double knockout and triple knockout ES cells were injected underneath the skin of athymic nude mice and teratomas were harvested, sectioned and stained with haematoxylin and eosin. Representative tissues of double knockout and triple knockout teratomas include muscle (mesoderm), respiratory epithelium (endoderm), skin and neural cells (ectoderm). d, Embryos derived from intercrosses between E2f1 1/2 E2f2 2/2 E2f3 1/2 mice were collected at various time points during pregnancies. Shown are the total number of embryos collected, with the number of dead embryos (round brackets) and total number of embryos expected (square brackets) also indicated. e, Representative E9.5 embryos were photographed immediately upon collection. LETTERS elevated in E2f1-3-deficient crypts, we failed to detect any significant increase in the expression of p53-responsive genes, and moreover, the conditional ablation of p53 (b-NF treated Ah-creE2f1 2/2 E2f2 2/2 E2f3 loxP/loxP p53 loxP/loxP ) did not suppress the apoptosis caused by E2f1-3 deficiency ( Supplementary Fig. 11b, c) . Together, these observations suggest that E2f1-3 are dispensable for cell division in the adult and that at least in the small intestine they function in a p53-independent manner to maintain DNA integrity and cell survival.
To understand the underlying mechanism for these unexpected results, we isolated crypt and villus cell populations from control and E2f1-3-deficient small intestines and analysed global gene expression profiles. Sample preparation and processing of the Affymetrix oligoarrays are described in the Methods section. We used an unbiased method similar to Gene Set Enrichment Analysis to identify genes that were differentially expressed 17 . Two variables contributed to the observed gene expression changes: cell compartment (crypt versus villus) and genotype (E2f1-3-deficient versus control). The cell compartment analysis compared gene expression in crypts and villi of the same genotype (Fig. 3a) . For control small intestines, this revealed that among the ,45,000 genes queried, 1,207 genes were upregulated and 2,363 genes were downregulated as progenitor cells in the crypt migrated up into the villus and exited the cell cycle (.1.5-fold, P , 0.0001; Supplementary Fig. 12a and Supplementary Table 1 ). As expected, the expression of most known E2f targets, as defined by previous gene expression 18 , reporter and chromatin immunoprecipitation assays 19 ( Supplementary Fig. 12b ), was markedly higher in control crypts than in associated villi (Fig. 3a, left panel) , consistent with the proliferative status of crypts. For E2f1-3-deficient small intestines, the expression of E2f targets in crypts was only marginally higher than in their associated villi (Fig. 3a, right panel) , suggesting that expression of these genes were either reduced in crypts, elevated in villi, or both.
The genotype analysis compared gene expression in E2f1-3deficient versus control samples of the same cell compartment. This comparison revealed a modest but significant downregulation of E2f targets in progenitor cells of E2f1-3-deficient crypts, which included many but not all known classic targets such as Cdc6, Ccna2, Ccne2, Top2 and Hmgb2 (Fig. 3b , c, left panels and Supplementary  Fig. 13a ). We suspect that continued proliferation of E2f1-3deficient progenitors in the small intestine when E2f targets are limiting probably contributes to replicative stress, DNA damage Crypt Crypt
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Figure 3 | Repression of E2f target genes in
E2f1-3-deficient villi. a, Scatter plots comparing expression of known E2f target genes (see Supplementary Fig. 12b ) between cell compartments (crypt and villus). Control, b-NF treated E2f1 2/2 E2f2 2/2 E2f3 loxP/loxP ; Ahe-cre, b-NF treated Ah-creE2f1 2/2 E2f2 2/2 E2f3 loxP/loxP . Genes with .1.5-fold increase in expression are depicted as red dots. b, Scatter plots comparing expression of known E2f target genes between genotypes (control and Ah-cre samples); n 5 3 for each of the four samples. Red dots indicate genes whose expression increased .1.5-fold and blue dots indicate genes that decreased .1.5-fold. c, Quantitative real-time PCR was performed to compare the relative expression of selected E2f target genes in control and Ah-cre crypts (left panels) and villi (right panels) using specific primers ( Supplementary Fig. 20 ). Error bars represent standard deviation from samples analysed in triplicate. d, Immunohistochemical staining of Mcm3 (green) and Pcna (red) in control and Ah-cre villi. DAPI (blue) was used for staining nuclei. Yellow dotted line outlines the luminal side of the villus; white dotted line outlines the outer side of the villus. Note that staining of blood cells in lumens of villi is nonspecific. e, The top panel shows chromatin immunoprecipitation (ChIP) assays using IgG or anti-E2f3 antibodies with lysates from wild-type villi (antibody control). The bottom panel shows ChIP assays using anti-E2f3 antibodies with lysates from wild type (ctrl) and Ah-creE2f1 2/2 E2f2 2/2 E2f3 loxP/loxP (triple knockout) villi (genotype control). Primers flanking known E2f-binding elements were used to detect the indicated gene promoters ( Supplementary Fig.  19 ). Error bars represent standard deviation from samples analysed in triplicate. f, Coimmunoprecipitation assays of cell extracts prepared from control villi and crypts. Immunoprecipitations (IP) used anti-E2f3 antibody or IgG. Anti-Rb antibody was used to probe western blot (WB; top panel). The specificity of the anti-E2f3 antibody was evaluated in intestinal lysates derived from b-NF treated Ah-creE2f1 2/2 E2f2 2/2 E2f3 loxP/loxP (3 2/2 ), E2f3a 2/2 (a 2/2 ), E2f3b 2/2 (b 2/2 ) and E2f3 1/1 (3 1/1 ) mice. Anti-Rb antibody was used to probe western blot (WB; bottom panel). and the observed increase in c-H2AX labelling in these cells. Whether these aberrant processes are linked to the death of E2f1-3-deficient progenitor cells remains to be evaluated rigorously. The genotype comparison also revealed a remarkable upregulation of a large number of E2f targets in differentiated cells of the E2f1-3-deficient villus (Fig. 3b, c, right panels, and Supplementary Fig. 13a ). Western blot assays and immunofluorescence staining showed that the accumulation of two of these E2f target gene products, Mcm3 and Pcna, was widespread throughout the E2f1-3-deficient villus ( Fig. 3d and Supplementary Fig. 13b ). Similarly, there was increased expression of E2f targets in differentiated E2f1-3-deficient cells of the retina and lens ( Supplementary Fig. 13c ; P.L.W., unpublished observations), suggesting a general role for E2f1-3 in transcriptional repression in postmitotic cells in vivo. Chromatin immunoprecipitation (ChIP) assays using villus-enriched lysates derived from control and E2f1-3-deficient small intestines showed that E2f3 occupies E2f binding sites on classic E2f target promoters (Fig. 3e) . Importantly, co-immunoprecipitation assays using intestinal epithelial cells derived from E2f3 2/2 , E2f3a 2/2 and E2f3b 2/2 villi showed that both E2f3a/b isoforms [20] [21] [22] participate in a complex with the Rb protein (Fig. 3f) . Consistent with this, Rb was found to be hypophosphorylated in the villus ( Supplementary Fig. 14a ). Together, these data indicate that E2f1-3 act as transcription activators in dividing progenitors, and as repressors (in complex with Rb) in differentiating cells of the small intestine.
The observation that E2f1-3 repress E2f targets and are dispensable for cell proliferation seems to contradict previous findings from the analysis of Rb/E2f double knockout animals 1, 2, 8 . Therefore, to explore thoroughly the mechanistic relationship between Rb and E2f1-3, we used the small intestine as an in vivo system where results could be uniformly compared across different genetic configurations. The Ah-cre-mediated inactivation of Rb in utero or in adult mice resulted in increased proliferation of cells in the villus compartment but not in the crypt (Fig. 4a, b and Supplementary Fig. 14b-e ), indicating that Rb-deleted transit-amplifying cells failed to exit the cell cycle appropriately. There was, however, no concomitant increase in apoptosis or defect in cell differentiation ( Supplementary Fig. 15a, b) , and as a result, Rb-deficient villi appeared uniformly hyperplastic. The combined ablation of E2f1, E2f2 and E2f3 completely suppressed the unscheduled proliferation and hyperplasia caused by Rb deficiency (b-NF treated Ah-creE2f1 2/2 E2f2 2/2 E2f3 loxP/loxP Rb loxP/loxP quadruple knockout; Fig. 4a, b and Supplementary Fig. 16a ). Notably, the basal levels of proliferation in quadruple knockout crypts were indistinguishable from control or E2f1-3-deficient samples ( Supplementary Fig. 16b ), consistent with the rather normal development of E2f1-3-deficient small intestines containing an intact Rb gene.
The selective requirement for E2f1-3 in the proliferation of Rbdeficient cells provided an opportunity to dissect possible cancerspecific mechanisms of E2f in cell cycle control. We therefore compared global gene expression programs in b-NF treated control, Ah-creRb loxP/loxP (Rb-deficient), Ah-creE2f1 2/2 E2f2 2/2 E2f3 loxP/loxP (E2f1-3-deficient) and Ah-creE2f1 2/2 E2f2 2/2 E2f3 loxP/loxP Rb loxP/loxP (Rb/E2f1-3-deficient) intestinal epithelia. Several important insights came from this analysis. First, there were expansive gene expression differences between control and Ah-creRb loxP/loxP villi (1,290 upregulated and 487 downregulated genes; Fig. 4c and Supplementary  Table 2 ), but relatively minor differences in their associated crypts ( Supplementary Fig. 17a, b ). Gene Ontology algorithms 23 identified a bias for differentially expressed genes involved in the regulation of transcription, DNA metabolic processes and cell cycle ( Supplementary  Table 3 ). Immunofluorescence and quantitative polymerase chain reaction with reverse transcription (RT-PCR) assays confirmed the marked accumulation of most E2f target genes in Rb-deficient villi (Supplementary Fig. 17c, d ). From these data we conclude that Rb is critical for the repression of E2f targets at a time when progenitor cells commit to exit the cell cycle and terminally differentiate. Second, hierarchical clustering of all data sets showed that E2f1-3-deficient and Rb/E2f1-3-deficient tissues clustered together in a separate group from control and Rb-deficient tissues ( Supplementary Fig. 18 ), indicating that some functions coordinated by E2f1-3 may be Rb-independent. Finally and most importantly, the expression levels of E2f targets in E2f1-3-deficient and Rb/E2f1-3-deficient villi were equivalent, and although higher than in control villi, they were substantially lower than in Rb-deficient villi (Fig. 4c ). Quantitative RT-PCR assays confirmed the relative expression of E2f targets to be: control , E2f1-3 deficient 5 Rb/E2f1-3 deficient = Rb deficient villi (Fig. 4d ). From these data, we conclude that the supra-elevated expression of E2f targets observed in Rb-deficient villi is due to both 'derepression' (lacking intact Rb-E2f1-3 repressor complexes) and E2f1-3-mediated 'hyper-activation'. In the absence of E2f1-3-mediated hyper-activation, cells in Rb/E2f1-3-deficient villi fail to hyper-activate and thus do not accumulate sufficient levels of E2f targets to undergo 'ectopic' cell proliferation (this threshold level of expression is illustrated as a red dotted line in Fig. 4d ).
We provide overwhelming evidence showing that normal cell proliferation in mice can be maintained in the absence of activator E2fs. We conclude that E2f1-3, like G1 Cdks [24] [25] [26] , are not as critical for normal cell proliferation in mammals as original studies implied 3, 4, [27] [28] [29] [30] . However, not all is well in the absence of E2f1-3, as b-NF treated Ah-creE2f1 2/2 E2f2 2/2 E2f3 loxP/loxP dividing progenitors in the small intestine undergo apoptosis. A pro-survival role for E2f1-3 was also evident in retinal progenitor cells of the mouse 15 LETTERS independent. Thus, the sensitivity of E2f1-3-deficient cells to p53 activation varies considerably across tissue types. The findings presented here also expose dual functions for E2f1-3 in transcription activation and repression in vivo. In dividing progenitor cells, when Rb is inactive (hyperphosphorylated), free E2f1-3 are used to optimally activate the expression of target genes. The inability to do so in E2f1-3-deficient tissues still permits cells to replicate their DNA and divide, but at the cost of increased DNA damage and cell death. As cells commit to a terminally differentiated fate, phosphorylated Rb is dephosphorylated and forms a physical complex with E2f1-3 proteins. We propose that this is not just to sequester E2f activators but rather, to form the first repressive complex that is necessary to downregulate E2f targets and usher transitamplifying cells out of the cell cycle. Once cells exit the cell cycle, other E2F repressor complexes accumulate, including p130-E2f4 and p107-E2f4, to more permanently enforce the repression of E2f targets. Given that inactivation of Rb, but not p107 or p130 (ref. 31 ), induces ectopic cell divisions in the small intestine, we suggest that Rb has a unique role in transit-amplifying cells that is dependent on its ability to associate with E2f1-3. Maintenance of quiescence in terminally differentiated cells of the villus, however, is a function that is shared among all members of the Rb family 31 . This work challenges the current paradigm of cell cycle control and provides a unified molecular view of how the dual functions of E2f1-3 in transcriptional activation and repression are used in vivo to control normal versus Rbmutant or cancer cell cycles.
METHODS SUMMARY
Mice (E2f1 2/2 , E2f2 2/2 , E2f3 f/f , Ah-cre and Rb f/f ) used for the studies were in a mixed background (129SvEv, C57BL/6NTac and FVB/NTac). b-Napthoflavone (Sigma; N3633-5G) was administered into 2-month-old Ah-cre mice three times within 24 h as described previously 14 , and mice were harvested 7 or 90 days later. b-Napthoflavone was also injected into pregnant female mice at 15.5 days post coitum for analysis of embryos at E18.5. Villus and crypt fractions were isolated as previously described 8 . Three independent samples from each genetic group were used for gene expression analysis by Affymetrix microarray. Analysis of gene expression data was performed using BRB-array tools developed by R. Simon and A. Peng Lam of the National Cancer Institute. Gene Ontologies were predicted by DAVID (Database for Annotation, Visualization and Integrated Discovery) Bioinformatics Resources at the National Institute of Allergy and Infectious diseases, NIH. X-gal staining, real-time RT-PCR, 5-bromodeoxyuridine (BrdU), ChIP and TUNEL assays were performed as previously described 8, 20 . Primers for ChIP, real-time RT-PCR and genotyping are listed in Supplementary Fig. 19a, b . Antibodies used for western blot or immunohistochemical staining are listed in Supplementary Fig. 19c .
